Navigation Links
Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Date:3/3/2009

RICHMOND, Calif., March 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(TM) development programs and an overview of the company's business strategy at two investor conferences during the month of March.

  • Barclays Capital Global Healthcare Conference at 3:45 pm ET, on Tuesday, March 10, 2009
  • Cowen and Company 29th Annual Health Care Conference at 8:00 am ET, on Wednesday, March 18, 2009

The presentations will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Sangamo also has a Phase 1 clinical trial to evaluate safety and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP trans
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
2. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
3. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
4. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
5. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
6. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
7. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
10. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
11. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)...  Four financial reasons to reduce pressure ulcers ... by Leaf Healthcare, Inc . According ... (AHRQ), pressure ulcers cost the US healthcare ... addition to direct treatment related costs, pressure ulcers ... impact hospital performance metrics. On top of the ...
(Date:9/3/2015)... Corporation (NASDAQ: OMER ) today announced that it ... and its subsidiary, Par Sterile Products, LLC, (collectively "Par") ... New Jersey and in the ... Delaware . The lawsuits were filed under the ... U.S. Patent Nos. 8,173,707, 8,586,633 and 9,066,856, which relate ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and ... of the "Investigation Report on China,s Levothyroxine ... Thyroid hormones (TH) have the greatest ... younger ones. Without thyroid hormones mainly promote the ... organs, even the growth hormone (GH) of pipuitary ...
Breaking Medicine Technology:Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4Investigation Report on China's Levothyroxine Market, 2010-2019 2
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... the real estate investment landscape by connecting accredited and institutional investors to real ... financing products designed to meet demand from both investors and sponsoring real ...
(Date:9/3/2015)... ... September 03, 2015 , ... Girl’s Night Out to benefit Core Compassion ... Farm, 6205 Kate Road in Monroe, North Carolina. The event food will ... social function, Kate Clyde’s offers off-premise catering and event services from casual to elegant. ...
(Date:9/3/2015)... WA (PRWEB) , ... September ... ... of Washington, a leading provider of comprehensive eating disorder treatment for adults ... announced today that Ileana Calinoiu, MD has joined the medical treatment team. ...
(Date:9/3/2015)... ... September 03, 2015 , ... According to an Oncology Nurse Advisor ... may help patients with oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated ... caused by HPV infections, which have a high rate of success in treatment and ...
(Date:9/3/2015)... ... September 03, 2015 , ... Atlantic ... virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” In this ... Scripts and Milliman, will discuss how plan sponsors are adopting bold, innovative strategies ...
Breaking Medicine News(10 mins):Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2
... ... ... ... ...
... - Researchers from The University of Texas M. D. ... to measure the severity of symptoms that can complicate ... chronic graft-versus-host disease (cGVHD), and was presented with supporting ... Meeting. cGVHD - a chronic disease that ...
... Radio ... This study appears in Plastic and Reconstructive Surgery, the offical medical journal of the American ... ... procedures in the world for excess fat removal - and while its relative safety and ...
... with type 1 disease from daily injections, expert predicts, , ... treatment with a hormone linked to weight loss seems to ... raising the prospect of a landmark new treatment for some ... as leptin, will work against type 1 diabetes. But if ...
... apt to enhance verbal skills, experts say, , MONDAY, ... their infants in front of supposedly brain-enhancing DVDs in ... be accomplishing nothing, new research shows. , What,s more, ... DVDs at an earlier age actually had lower levels ...
... ... ... ... ...
Cached Medicine News:Health News:Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference 2Health News:Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference 3Health News:Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference 4Health News:Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference 5Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 2Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 3Health News:New Study Tunes Into Latest Lipo Technique 2Health News:Hormone Outperforms Insulin in Diabetic Mice 2Health News:Watching Special Videos May Not Make Kids Brainier 2Health News:Watching Special Videos May Not Make Kids Brainier 3Health News:National Study Reports Staggering Spending Increases Among Seniors With Chronic Conditions Through Original Medicare - Special Needs Plan Program Offers Solution For Those In Texas 2Health News:National Study Reports Staggering Spending Increases Among Seniors With Chronic Conditions Through Original Medicare - Special Needs Plan Program Offers Solution For Those In Texas 3Health News:National Study Reports Staggering Spending Increases Among Seniors With Chronic Conditions Through Original Medicare - Special Needs Plan Program Offers Solution For Those In Texas 4
... The only catheter of its kind, ... rapidly collects real-time cardiac electrical information, ... map. With 64 electrodes, this unique ... more than 3,000 points of electrical ...
Wire mesh braided design with a platinum core....
... Jude Medical's universal programmer platform, the ... in combination with St. Jude Medical® ... for emerging indications. Features a ... active matrix LCD screen Programmer offers ...
Inquire...
Medicine Products: